Want to see HK:2293 full AI Analyst Report?
Bamboos Health Care Holdings Ltd (2293) AI Stock Analysis
Top Page
Bamboos Health Care Holdings Ltd
(HKEX:2293)
The score is driven primarily by mixed financial performance: strong current profitability and a conservative balance sheet are offset by declining revenue since 2022, margin/ROE deterioration, and less convincing cash-flow quality versus earlier years. Valuation is a positive (moderate P/E and high yield), but technical indicators remain weak with negative MACD and price below key moving averages.
Bamboos Health Care Holdings Ltd (2293) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 162.45M
- Dividend Yield
- 9.88%
- Average Volume (3M)
- 88.00K
- Price to Earnings (P/E)
- 26.1
- Beta (1Y)
- 0.25
- Revenue Growth
- -10.65%
- EPS Growth
- -64.30%
- Country
- Hong Kong
- Employees
- 92
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Staffing & Employment Services
Bamboos Health Care Holdings Ltd Business Overview & Revenue Model
Company Description
Bamboos Health Care Holdings Limited functions as an investment holding entity primarily dedicated to furnishing healthcare workforce solutions throughout Hong Kong. Its extensive array of services includes vital support for medical facilities and ta...
How the Company Makes Money
null
Bamboos Health Care Holdings Ltd Financial Statement Overview
Summary
Financials show resilience but weakening momentum. Profitability is still solid (latest gross margin ~42%, net margin ~24%) and leverage is modest (debt-to-equity ~0.27–0.33), supporting stability. However, revenue fell materially in 2025 (~-13%) after a multi-year decline since 2022, margins have compressed versus prior peaks, ROE has dropped to ~7.6% in 2025, and cash flow—while positive—appears less robust with reduced transparency from inconsistent 2025 cash-conversion fields.
Income Statement
62PositiveBalance Sheet
78PositiveCash Flow
58Neutral| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.44M | 66.71M | 74.40M | 94.79M | 126.56M | 140.29M |
| Gross Profit | 24.79M | 29.59M | 31.00M | 84.72M | 115.12M | 91.33M |
| EBITDA | 18.30M | 15.30M | 34.98M | 52.76M | 69.85M | 81.32M |
| Net Income | 6.24M | 6.24M | 17.54M | 30.92M | 46.92M | 58.62M |
Balance Sheet | ||||||
| Total Assets | 325.22M | 325.22M | 315.90M | 318.06M | 346.83M | 351.35M |
| Cash, Cash Equivalents and Short-Term Investments | 35.33M | 35.33M | 52.96M | 81.15M | 93.27M | 86.27M |
| Total Debt | 58.71M | 58.71M | 62.13M | 63.73M | 68.24M | 68.96M |
| Total Liabilities | 77.88M | 77.88M | 86.54M | 99.74M | 124.51M | 140.75M |
| Stockholders Equity | 247.34M | 247.34M | 229.36M | 218.33M | 222.32M | 210.60M |
Cash Flow | ||||||
| Free Cash Flow | 6.92M | 0 | 35.03M | 35.75M | 41.67M | 100.37M |
| Operating Cash Flow | 6.92M | 0 | 36.84M | 37.41M | 41.94M | 116.11M |
| Investing Cash Flow | -2.72M | 0 | -51.58M | -7.09M | 6.92M | -111.63M |
| Financing Cash Flow | -8.73M | 0 | -22.82M | -42.44M | -41.80M | 25.15M |
Bamboos Health Care Holdings Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2293, the sentiment is Negative. The current price of 0.41 is below the 20-day moving average (MA) of 0.41, above the 50-day MA of 0.39, and below the 200-day MA of 0.41, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 48.18 is Neutral, neither overbought nor oversold. The STOCH value of 68.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2293.
Bamboos Health Care Holdings Ltd Peers Comparison
Overall Rating
- HK:229364Neutral
HK:213555Neutral
HK:663948Neutral
HK:072242Neutral
HK:388641Neutral
HK:830737Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2293 | 64Neutral | HKD 163.00M | 26.13 | 2.49% | 9.88% | -10.65% | -64.30% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| HK:2135 | 55Neutral | HKD 62.39M | 3.94 | 12.17% | ― | 36.68% | ― |
| HK:6639 | 48Neutral | HKD 1.03B | 31.06 | 1.27% | ― | ― | ― |
| HK:0722 | 42Neutral | HKD 292.35M | -3.79 | -10.76% | 9.04% | -1.37% | -334.69% |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
| HK:8307 | 37Underperform | HKD 60.30M | 64.28 | 19.79% | ― | 6.13% | ― |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2293 | Bamboos Health Care Holdings Ltd | 0.41 | -0.16 | -27.68% | |
| HK:2135 | Raily Aesthetic Medicine International Holdings Limited | 0.11 | -0.00 | -3.45% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:6639 | Arrail Group Ltd. | 1.83 | -0.09 | -4.74% | |
| HK:0722 | UMP Healthcare Holdings Limited | 0.36 | -0.07 | -16.67% | |
| HK:8307 | Medicskin Holdings Ltd. | 0.15 | -0.03 | -15.56% |
Bamboos Health Care Holdings Ltd Corporate Events
Bamboos Health Care Announces Resignation of Executive Director
Bamboos Health Care Holdings Ltd has announced that executive director Mr. Cheng Sau Kong will resign from the board with effect from 22 May 2026. The company said Mr. Cheng is stepping down to focus on other engagements and business commitments, and...
Bamboos Health Care Revamps Board and Committee Roles Effective May 2026
Bamboos Health Care Holdings Limited has updated the composition of its board of directors effective 22 May 2026, confirming Ms. Hai Hiu Chu as executive director, chairman and chief executive officer, supported by three independent non-executive dir...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jul 08, 2026